Autonomix Medical, Inc. Common Stock (AMIX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Autonomix Medical, Inc. Common Stock (AMIX) has a cash flow conversion efficiency ratio of -1.121x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.54 Million) by net assets ($3.16 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Autonomix Medical, Inc. Common Stock market capitalisation for the company's overall valuation and market capitalisation.
Autonomix Medical, Inc. Common Stock - Cash Flow Conversion Efficiency Trend (2022–2026)
This chart illustrates how Autonomix Medical, Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Autonomix Medical, Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Autonomix Medical, Inc. Common Stock ranked by their cash flow conversion efficiency. Explore cash flow quality index of Autonomix Medical, Inc. Common Stock to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Movinn AS
CO:MOVINN
|
0.021x |
|
EVE Health Group Limited
AU:EVE
|
-0.242x |
|
CCH Holdings Ltd Ordinary Shares
NASDAQ:CCHH
|
N/A |
|
Wi2Wi Corporation
V:YTY
|
-0.128x |
|
Madoro Metals Corp
V:MDM
|
-0.030x |
|
iDimension Consolidated Bhd
KLSE:0174
|
0.001x |
|
Euroespes S.A.
MC:EEP
|
0.003x |
|
Oriental Trimex Limited
NSE:ORIENTALTL
|
0.008x |
Annual Cash Flow Conversion Efficiency for Autonomix Medical, Inc. Common Stock (2022–2026)
The table below shows the annual cash flow conversion efficiency of Autonomix Medical, Inc. Common Stock from 2022 to 2026. View AMIX live share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | $5.89 Million | $-12.28 Million | -2.083x | -104.33% |
| 2025-03-31 | $8.10 Million | $-8.26 Million | -1.020x | -16.99% |
| 2024-03-31 | $7.63 Million | $-6.65 Million | -0.872x | +69.73% |
| 2023-03-31 | $644.00K | $-1.85 Million | -2.880x | -1356.83% |
| 2022-03-31 | $1.96 Million | $-387.31K | -0.198x | -- |
About Autonomix Medical, Inc. Common Stock
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders of nervous system. The company's technology platform includes a catheter-based system incorporating microchip-enabled sensing architecture designed to detect low-amplitude neural signals from within the vascular system. It develops technology for patients with … Read more